The Natural History of Carbapenemase-Producing Enterobacterales: Progression From Carriage of Various Carbapenemases to Bloodstream Infection
Clinical Infectious Diseases · 19.07.2024 · 79 (1) · 22-29
DOI: 10.1093/cid/ciae110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 06.03.2024. Verfasst von Elizabeth Temkin und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Antibiotic Resistance and Infection Control, Tel Aviv, Israel. Hauptthemen laut MEDLINE: beta-Lactamases, Bacterial Proteins, Enterobacteriaceae Infections, Bacteremia. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Background
Little is known about the risk of progression from carbapenemase-producing Enterobacterales (CPE) carriage to CPE bloodstream infection (BSI) outside of high-risk settings. We aimed to determine the incidence of CPE BSI among CPE carriers and to assess whether the incidence differs by carbapenemase, species, and setting.
Methods
We conducted a nationwide population-based retrospective cohort study using national databases. The cohort consisted of all patients in Israel with CPE detected by screening from 1 January 2020 to 10 October 2022. We calculated the cumulative incidence of CPE BSI within 1 year among CPE carriers. We used a competing-risks model with BSI as the outcome and death as the competing risk.
Results
The study included 6828 CPE carriers. The cumulative incidence of CPE BSI was 2.4% (95% confidence interval [CI], 2.1–2.8). Compared with Klebsiella pneumoniae carbapenemase (KPC), the subhazard of BSI was lower for New Delhi metallo-β-lactamase (NDM) (adjusted subhazard ratio [aSHR], 0.72; 95% CI, .49–1.05) and oxacillinase-48-like (OXA-48-like) (aSHR, 0.60; 95% CI, .32–1.12) but these differences did not reach statistical significance. Compared with K. pneumoniae, the subhazard of BSI was lower for carriers of carbapenemase-producing Escherichia coli (aSHR, 0.33; 95% CI, .21–.52). The subhazard of BSI was higher among patients with CPE carriage first detected in intensive care units (aSHR, 2.10; 95% CI, 1.27–3.49) or oncology/hematology wards (aSHR, 3.95; 95% CI, 2.51–6.22) compared with medical wards.
Conclusions
The risk of CPE BSI among CPE carriers is lower than previously reported in studies that focused on high-risk patients and settings. The risk of BSI differs significantly by bacterial species and setting, but not by carbapenemase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute for Antibiotic Resistance and Infection Control, Tel Aviv, Israel.
- National Institute for Antibiotic Resistance and Infection Control and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Zitieren
APA
Temkin, E., Solter, E., Lugassy, C., Chen, D., Cohen, A., Schwaber, M. J., Carmeli, Y., & CPE Working Group (2024). The Natural History of Carbapenemase-Producing Enterobacterales: Progression From Carriage of Various Carbapenemases to Bloodstream Infection. Clinical Infectious Diseases, 79(1), 22-29. https://doi.org/10.1093/cid/ciae110
Vancouver
Temkin E, Solter E, Lugassy C, Chen D, Cohen A, Schwaber MJ, et al. The Natural History of Carbapenemase-Producing Enterobacterales: Progression From Carriage of Various Carbapenemases to Bloodstream Infection. Clinical Infectious Diseases. 2024;79(1):22-29. doi:10.1093/cid/ciae110
BibTeX
@article{Temkin2024,
author = {Temkin, Elizabeth and Solter, Ester and Lugassy, Carmela and Chen, Dafna and Cohen, Adi and Schwaber, Mitchell J and Carmeli, Yehuda and CPE Working Group, CPE Working Group},
title = {The Natural History of Carbapenemase-Producing Enterobacterales: Progression From Carriage of Various Carbapenemases to Bloodstream Infection},
journal = {Clinical Infectious Diseases},
year = {2024},
volume = {79},
number = {1},
pages = {22--29},
doi = {10.1093/cid/ciae110}
}
EUVIMED